| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Institute for Virus Research, Kyoto University, Shogoin-kawahara-cho, Sakyo-ku, Kyoto 606, Japan
We constructed a series of human immunodeficiency virus 1 (HIV-1)/simian immunodeficiency virus strain mac (SIVmac) chimeric viruses having vpr and/or nef genes of either HIV-1 or SIVmac based on a chimeric virus with LTRs, gag, pol, vif and vpx derived from SIVmac and tat, rev, vpu and env from HIV-1. All of the chimeric viruses replicated in human and macaque peripheral blood mononuclear cells (PBMCs) and in several CD4+ human cell lines, though their growth potentials were slightly different depending on whether vpr and nef were from HIV-1 or SIVmac, or were defective. The presence of nef accelerated replication in all the cells used and the replication of each chimera appeared to reflect that of the parental virus from which nef was derived. The presence of vpr had no clear effect in human and monkey PBMCs, but the replication of each chimera was influenced by the origin of vpr in H9 and A3.01 cells. NM-3rN, which carries HIV-1 vpr and SIVmac nef, was inoculated intravenously into three rhesus monkeys, three cynomolgus monkeys and two pig-tailed monkeys. From 2 to 14 weeks after inoculation, viruses were consistently re-isolated from all the monkeys and virus loads were as high as that of SIVmac reported previously. The results indicate that infection with NM-3rN is more efficient than any of our previous chimeric viruses and suggest that NM-3rN, having HIV-1 Env, will be a useful challenge virus for evaluating AIDS vaccines based on HIV-1 Env in macaque monkeys instead of chimpanzees.
* Author for correspondence. Fax +81 75 761 9335. e-mail mhayami@virus.kyoto-u.ac.jp
Received 9 February 1995;
accepted 27 April 1995.
This article has been cited by other articles:
|
|
 |
|
  W. Akahata, E. Ido, H. Akiyama, H. Uesaka, Y. Enose, R. Horiuchi, T. Kuwata, T. Goto, H. Takahashi, and M. Hayami DNA vaccination of macaques by a full-genome simian/human immunodeficiency virus type 1 plasmid chimera that produces non-infectious virus particles J. Gen. Virol., August 1, 2003; 84(8): 2237 - 2244. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Akiyama, E. Ido, W. Akahata, T. Kuwata, T. Miura, and M. Hayami Construction and in vivo infection of a new simian/human immunodeficiency virus chimera containing the reverse transcriptase gene and the 3' half of the genomic region of human immunodeficiency virus type 1 J. Gen. Virol., July 1, 2003; 84(7): 1663 - 1669. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Akahata, E. Ido, and M. Hayami Mutational analysis of two zinc-finger motifs in the nucleocapsid protein of simian immunodeficiency virus mac239 J. Gen. Virol., June 1, 2003; 84(6): 1641 - 1648. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. L. Kozyrev, T. Miura, T. Takemura, T. Kuwata, M. Ui, K. Ibuki, T. Iida, and M. Hayami Co-expression of interleukin-5 influences replication of simian/human immunodeficiency viruses in vivo J. Gen. Virol., May 1, 2002; 83(5): 1183 - 1188. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Mooij, W. M. J. M. Bogers, H. Oostermeijer, W. Koornstra, P. J. F. Ten Haaft, B. E. Verstrepen, G. Van Der Auwera, and J. L. Heeney Evidence for Viral Virulence as a Predominant Factor Limiting Human Immunodeficiency Virus Vaccine Efficacy J. Virol., May 1, 2000; 74(9): 4017 - 4027. [Abstract] [Full Text]
|
|
|
|
|
|
J. M. Crawford, P. L. Earl, B. Moss, K. A. Reimann, M. S. Wyand, K. H. Manson, M. Bilska, J. T. Zhou, C. D. Pauza, P. W. H. I. Parren, et al. Characterization of Primary Isolate-Like Variants of Simian-Human Immunodeficiency Virus J. Virol., December 1, 1999; 73(12): 10199 - 10207. [Abstract] [Full Text]
|
|
|
|
|
|
E. J. Verschoor, P. Mooij, H. Oostermeijer, M. van der Kolk, P. ten Haaft, B. Verstrepen, Y. Sun, B. Morein, L. Åkerblom, D. H. Fuller, et al. Comparison of Immunity Generated by Nucleic Acid-, MF59-, and ISCOM-Formulated Human Immunodeficiency Virus Type 1 Vaccines in Rhesus Macaques: Evidence for Viral Clearance J. Virol., April 1, 1999; 73(4): 3292 - 3300. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
